These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2655690)

  • 1. Cyclosporin-erythromycin interaction in renal transplant patients.
    Gupta SK; Bakran A; Johnson RW; Rowland M
    Br J Clin Pharmacol; 1989 Apr; 27(4):475-81. PubMed ID: 2655690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin-erythromycin interaction in normal subjects.
    Freeman DJ; Martell R; Carruthers SG; Heinrichs D; Keown PA; Stiller CR
    Br J Clin Pharmacol; 1987 Jun; 23(6):776-8. PubMed ID: 3606938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of clarithromycin on the bioavailability of cyclosporin in rats.
    Ohba M; Ohnishi N; Komada F; Iwakawa S; Okumura K
    Biol Pharm Bull; 1996 May; 19(5):733-7. PubMed ID: 8741585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interaction between cyclosporin and diltiazem.
    Brockmöller J; Neumayer HH; Wagner K; Weber W; Heinemeyer G; Kewitz H; Roots I
    Eur J Clin Pharmacol; 1990; 38(3):237-42. PubMed ID: 2340843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of cyclosporin.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ
    Clin Pharmacokinet; 1986; 11(2):107-32. PubMed ID: 3514043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of spiramycin on cyclosporin pharmacokinetics.
    Vernillet L; Bertault-Peres P; Berland Y; Barradas J; Durand A; Olmer M
    Br J Clin Pharmacol; 1989 Jun; 27(6):789-94. PubMed ID: 2667601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saturable binding of cyclosporin A to erythrocytes: estimation of binding parameters in renal transplant patients and implications for bioavailability assessment.
    Legg B; Rowland M
    Pharm Res; 1988 Feb; 5(2):80-5. PubMed ID: 3073383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cyclosporine assay methodology in the immediate postoperative period of renal transplantation.
    Morse GD; Holdsworth MT; Walshe JJ
    Ther Drug Monit; 1989; 11(3):238-45. PubMed ID: 2658209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A and erythromycin: a study of a drug interaction in the in situ perfused rat liver model.
    Hughes CM; Swanton JG; Collier PS
    Biopharm Drug Dispos; 1993 Oct; 14(7):615-25. PubMed ID: 8251616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent dose-dependent oral absorption of cyclosporin A in rats.
    Ueda CT; Lemaire M; Gsell G; Misslin P; Nussbaumer K
    Biopharm Drug Dispos; 1984; 5(2):141-51. PubMed ID: 6743782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary pharmacokinetic study of cyclosporine A in 10 Japanese renal transplant patients.
    Takada K; Yoshikawa H; Muranishi S; Nagano S; Fukunishi T
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):438-42. PubMed ID: 3308718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
    Frey BM; Sieber M; Mettler D; Gänger H; Frey FJ
    Drug Metab Dispos; 1988; 16(2):285-9. PubMed ID: 2898348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bile on cyclosporin absorption in liver transplant patients.
    Mehta MU; Venkataramanan R; Burckart GJ; Ptachcinski RJ; Delamos B; Stachak S; Van Thiel DH; Iwatsuki S; Starzl TE
    Br J Clin Pharmacol; 1988 May; 25(5):579-84. PubMed ID: 3044424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteric solid dispersion of cyclosporin A (CyA) having potential to improve availability of CyA in rabbit.
    Takada K; Oh-hashi M; Furuya Y; Yoshikawa H; Muranishi S
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2542-4. PubMed ID: 2605708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and metabolism of cyclosporin; drug interactions].
    Le Bigot JF; Lavene D; Kiechel JR
    Nephrologie; 1987; 8(3):135-41. PubMed ID: 3658089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cyclosporin: influence of rate of constant intravenous infusion in renal transplant patients.
    Gupta SK; Legg B; Solomon LR; Johnson RW; Rowland M
    Br J Clin Pharmacol; 1987 Oct; 24(4):519-26. PubMed ID: 3318898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic of cyclosporin A].
    Bourdat-Michel G; Dechelette E; Serre-Debeauvais F; Bost M; Beaudoing A
    Pediatrie; 1990; 45(9):571-5. PubMed ID: 2175417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin-phenytoin interaction: re-evaluation using metabolite data.
    Rowland M; Gupta SK
    Br J Clin Pharmacol; 1987 Sep; 24(3):329-34. PubMed ID: 3663449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model to account for the blood-to-plasma distribution of cyclosporin A in human blood.
    Shibata N; Minouchi T; Ono T; Shimakawa H
    J Pharmacobiodyn; 1990 Jan; 13(1):20-9. PubMed ID: 2341967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine metabolite concentrations in the blood of liver, heart, kidney, and bone marrow transplant patients.
    Wang CP; Burckart GJ; Ptachcinski RJ; Venkataramanan R; Schwinghammer T; Hakala T; Griffith B; Hardesty R; Shadduck R; Knapp J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):591-6. PubMed ID: 3284107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.